PyInvesting

Market research

RT2.F Surgalign Holdings, Inc

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
39M
P/E ratio
Not available
Analyst target
3.36
Dividend yield
0.0%
Beta
2.11

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Surgalign Holdings, Inc is currently in a long term downtrend where the price is trading 37.6% below its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.

Surgalign Holdings, Inc's total revenue sank by 67.4% to $26M since the same quarter in the previous year.

Its net income has increased by 49.6% to $-100M since the same quarter in the previous year.

Finally, its free cash flow fell by 2975.4% to $-16M since the same quarter in the previous year.

Based on the above factors, Surgalign Holdings, Inc gets an overall score of 2/5.